| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9e3b6014b56c428f90df9198c169cb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b72691b61448140b9a080282c2ccf0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B30-10 |
| filingDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d2fb1390a67c7a1712605a98f69128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6e6da9b5af640c930555784c890028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65eec8411717fbce1b641de3efe3b9e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25ee71c743d239d01b018ff179abc21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ce1981b934497bb6b706ebebdeaea76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe88ee4d381355eb85e297e10c1cdff8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fde87cd8e41af270561545d045567fb |
| publicationDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200101106-A |
| titleOfInvention |
Method for Prognosing Hepatic Cancer Patients Based on Circulating Cell Free DNA |
| abstract |
The present invention relates to a method for predicting prognosis of liver cancer treatment based on blood cell-free DNA. The liver cancer prognosis prediction method according to the present invention uses Next Generation Sequencing (NGS) to improve the prognostic accuracy of liver cancer patients, as well as the prognostic accuracy based on a very low concentration of cell-free DNA that was difficult to detect. It can increase commercial utilization by increasing the value. Therefore, the method of the present invention is useful for determining the prognosis of patients with liver cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113127533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022250512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022250513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022108407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113517023-A |
| priorityDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |